Home Cart Sign in  
Chemical Structure| 165393-06-6 Chemical Structure| 165393-06-6

Structure of Urolithin C
CAS No.: 165393-06-6

Chemical Structure| 165393-06-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Urolithin C, a gut-microbial metabolite of Ellagic acid, is a glucose-dependent activator of insulin secretion. Urolithin C is a L-type Ca2+ channel opener and enhances Ca2+ influx. Urolithin C induces cell apoptosis through a mitochondria-mediated pathway and also stimulates reactive oxygen species (ROS) formation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Urolithin C

CAS No. :165393-06-6
Formula : C13H8O5
M.W : 244.20
SMILES Code : O=C1C2=CC(O)=C(O)C=C2C3=C(O1)C=C(O)C=C3
MDL No. :MFCD20275232
InChI Key :HHXMEXZVPJFAIJ-UHFFFAOYSA-N
Pubchem ID :60198001

Safety of Urolithin C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat pancreatic islets 20 µM 1 hour Urolithin C significantly enhanced insulin secretion under 8.3 mM glucose stimulation Br J Pharmacol. 2019 Oct;176(20):4065-4078
INS-1 beta cells 2-20 µM 1 hour To evaluate the effect of Urolithin C on glucose-stimulated insulin secretion, results showed Urolithin C significantly enhanced insulin secretion at 20 μM Br J Pharmacol. 2019 Oct;176(20):4065-4078
Human gut bacterial strain CEBAS 4A4 15 mM 13 days Transformation of EA into urolithins M6, C, and isourolithin A Front Microbiol. 2017 Aug 7;8:1521
MIN6 cells 25 µM 24 hours To evaluate the effect of UC on cytokine-treated MIN6 cell proliferation, apoptosis, and insulin secretion, it was found that UC significantly promoted cell proliferation, reduced apoptosis and DNA damage, and reversed the inhibitory effect of cytokines on insulin secretion. Nutr Diabetes. 2023 Dec 1;13(1):24
MIN6 cells 0, 2.5, 5, 15, 25, 50 or 100 µM 24 hours To evaluate the effect of UC on MIN6 cell viability, it was found that low doses of UC (0, 2.5, 5, 15 and 25 µM) did not affect cell viability, while 50 and 100 µM UC showed increasing cytotoxicity. Nutr Diabetes. 2023 Dec 1;13(1):24

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats Isolated perfused pancreas model Perfusion 20 μM Continuous for 30 minutes Urolithin C significantly enhanced insulin secretion under 8.3 mM glucose stimulation, and the effect was reversible Br J Pharmacol. 2019 Oct;176(20):4065-4078
NOD mice Non-obese diabetic mouse model Oral gavage 50 mg/kg/day Once daily for 4 weeks (early intervention) or 10 weeks (late intervention) To evaluate the protective effect of UC on T1D progression, it was found that UC significantly reduced diabetes incidence, attenuated insulitis, elevated insulin levels and GSIS, and reduced blood glucose and AUC. Nutr Diabetes. 2023 Dec 1;13(1):24

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.10mL

0.82mL

0.41mL

20.48mL

4.10mL

2.05mL

40.95mL

8.19mL

4.10mL

References

 

Historical Records

Categories